Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience -- Ignore unavailable to you. Want to Upgrade?

To: growthvalue who wrote (404)	9/17/1998 10:29:00 AM
From: kathleen	Respond to of 586

Well I'm not really sure but I don't think there are that many plasmapheresis machines out there. The only places I've heard of that give plasmapheresis down here are big regional major medical centers hours away.

To: growthvalue who wrote (404)	9/23/1998 4:06:00 AM
From: kathleen	Read Replies (2) \| Respond to of 586

Found this info on the prosorba column. Thought it was a good explanation..... PROSORBA COLUMN On September 16 Cypress Bioscience, Inc. announced that an FDA advisory panel had recommended approval of its Prosorba column for the treatment of rheumatoid arthritis. The Prosorba column is not a drug or a medication: it is a plastic cylinder that contains highly purified Protein A immobilized on a silica matrix. Protein A binds to antibodies which contribute to inflammation. Blood is drawn from a patient's arm and passed through a plasmopheresis machine, which separates the blood cells from the blood plasma. The plasma then passes through the Prosorba column, where certain antibodies are removed and additional immunomodulatory effects occur. Then the blood is returned to the patient's other arm. The procedure takes about two and a half hours and is performed once a week for twelve weeks. In clinical trials, about half of patients showed significant improvement after treatment; the ones who did improve maintained the improvement up to 40 weeks after treatment. Source of information: BW HealthWire release by Cypress Biosciences, Inc.